Nour Drai

• Strong knowledge of the Canadian healthcare landscape, including regulations, policies, and market dynamics
• Development of reimbursement strategies in a constantly changing environment with fierce competition, executing access strategies, and adapting as needed
• Collaboration with Global teams to adapt access strategy and economic models to the Canadian market
• Reimbursement submissions to public payers (CADTH, INESSS, provinces)
• Preparation of Private Payor drug reimbursement submissions (when applicable)
• Engagement with key stakeholders (awareness or advocacy): collaboration with HCPs, HTAs, and patient advocacy groups to understand their needs and concerns
• Managing budgets and financial resources (e.g., vendor proposals)
• Flexibility to work on multiple indications/with multiple brand teams
• Collaborating cross-functionally to achieve goals: collaborate closely with medical affairs, marketing, regulatory affairs, and other teams to align efforts and achieve market access goals.

• Strong understanding and intelligence of the health economics environment and its dynamics
• Analysis of files submitted by drug manufacturers, related to pharmacoeconomic aspects (cost-effectiveness models), as well as budget impacts, teamed with internal and external experts (all therapeutic areas)
• Medical writing of reports, recommendations, notices to the Minister, letters to manufacturers, letters or press releases regarding recommendation information
• Advising on the pharmacoeconomic aspects and the impact of the drug registration on population health and other components of the healthcare system by providing the required scientific, epidemiological, pharmacoeconomic and economic expertise
• Analysis of partitioned survival models/Markov models and budget impact analyzes development from scratch, with data from the RAMQ database and CDH (IQVIA).

• Economic model Canadian adaptation (Liaises with Global HEOR teams)
• Contribution to budget impact analysis development
• Clinical summary medical writing
• Validation of inputs, models, and reports (working with consultants)
• Contribution to submissions to INESSS, CADTH and private payers
• Interdepartmental projects: medical affairs, marketing intelligence, Regulatory affairs and pricing to complete submissions and meet payers requirements
• Environmental scanning: Identification of competitors, market trends, province recommendations/criteria.

• Updates of SRDs (scientific response documents) using research in the literature

• Translation of SRDs

• Creation of medication pages (pfizer website - medical information) for all the products,

• Summary of scientific articles (training + application)

• Research project on anti-PD1 drugs (immunooncology).

• Followed quality standards and procedures to minimize errors and maximize customer satisfaction.
• Evaluated quality problems and performed assessments to identify and resolve issues.
• Improved quality processes for increased efficiency and effectiveness.
• Updated quality control standards, methods, and procedures to meet compliance requirements.